Google News – Clinical Trials External News
Biotechnology Articles
Google News – Clinical Trials External News
Recently, a personalized messenger ribonucleic acid (mRNA) cancer treatment vaccine jointly develope.. - 매일경제
Google News – Clinical Trials External News
AbbVie-backed ADARx plans IPO to bankroll array of clinical-stage siRNA therapies - Fierce Biotech
Google News – Biotech Funding External News
Big pharma eyes Australian biotech as $300b patent cliff looms - AFR
Google News – FDA (biotech/pharma) External News
AstraZeneca’s Etcamah combo approved by FDA - The Pharma Letter
Industry News External News
IIL stands by rabies vaccine, as CDSCO flags ‘fake’ vials seized from unlicensed Delhi residence - BusinessLine
Google News – Oncology External News
ORIC stock holds steady as biotech eyes next trial and earnings - AD HOC NEWS
Google News – FDA (biotech/pharma) External News
CRISPR Therapeutics gains FDA approval for CASG... - Pluang
Industry News External News
Abhayrab rabies vaccine batch flagged as substandard in India - BusinessLine
Google News – FDA (biotech/pharma) External News
FDA backs AstraZeneca's oral SERD despite adcom concerns - FirstWord Pharma
Google News – Pharmaceuticals External News
ADRX IPO News - siRNA biotech ADARx Pharmaceuticals files for a $100 million IPO - renaissancecapital.com
Google News – Pharmaceuticals External News
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now? - The Motley Fool
Google News – FDA (biotech/pharma) External News
FDA green light for Zanvastro in Alexander disease - The Pharma Letter
Google News – Pharmaceuticals External News
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now? - Currently.com
Google News – FDA (biotech/pharma) External News